This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Study sample
No sample size appears to have been determined in the planning phase of the study. In addition, no retrospective power calculations were reported. The participants were identified from two years' worth of MCO claims from pregnant members either assigned or not assigned to the Right Start programme. For the two years of the study there were 2,338 births (2,252 single births and 86 multiple births) in the Right Start group and 3,753 (3,629 single births and 124 multiple births) in the non-Right Start group. The authors did not provide any more baseline characteristics of the mothers.
Study design
This was a retrospective cohort study that was undertaken in a single MCO. The groups were followed-up until the birth of the infant(s). Hence, there was no loss to follow-up.
Analysis of effectiveness
All the participants included in the study appear to have been accounted for in the analysis. The primary health outcome was the proportion of low birth weight infants in each group. For the purpose of the analysis, low birth weight included infants with very low birth weight (<750 g to <2,500 g) as one population, and no differentiation was made between these two groups. Numbers of low birth weights were as defined by Medicare Diagnosis Related Groups (DRG) codes. The DRG codes used for low birth weight were 602 -621 (for very low birth weight the codes were 602 -608).
The authors did not report any baseline characteristics, nor did they report whether the patient groups were similar. However, they reported that pregnant members at higher risk for delivering low birth weight infants were identified for participation in the Right Start programme entirely at the discretion of their provider. Therefore, the authors concluded that members of the Right Start programme were selectively at higher risk for low birth weight deliveries, per the judgement of the provider.
Effectiveness results
In the years 1999 and 2000, of the total 2,338 births in the Right Start group, 72 (3%) infants were considered to be of low birth weight, compared with 230 (6%) of the 3,753 total births in the non-Right Start group.
Clinical conclusions
The Right Start programme was more effective than current practice in the MCO at preventing low birth weight, even though members of the Right Start programme were selectively at higher risk for low birth weight deliveries, per the judgement of the provider.
Measure of benefits used in the economic analysis
The authors did not derive a summary measure of health benefit. The analysis was, in effect, a cost-consequences study.
Direct costs
The direct costs included were those of the MCO. These comprised the costs of the first year of life for low birth weight and normal weight infants, and the investment costs of the project. The latter (investment costs) covered personnel allocation, mailing costs, provider reimbursement and other miscellaneous costs such as non-mailing media, programme marketing-related travel and expenses. Using these two costs the authors also calculated the ROI of the Right Start Programme. ROI was calculated as the net savings associated with the programme divided by the net costs of the programme. The costs associated with the first year of life for infants were derived from the Return on Investment Right Start Program Executive Summary. The costs and the quantities were not reported separately. Discounting was unnecessary, as the costs were incurred during one year, and was not performed. The price years were 1999 and 2000. The study reported the incremental costs. without 'gold' standard, randomised double-blind studies it was difficult to prove if success was due to the case management interventions alone used for the Right Start programme. However, the assignment would appear to have biased against the Right Start programme, as patients in this group were considered to be at higher risk of having a low birth weight. The authors did not use any statistical tests to examine whether differences in low birth weights between the two groups were statistically significant.
Validity of estimate of measure of benefit
The authors did not derive a summary measure of health benefit. The analysis was therefore categorised as a costconsequences study. The comments in the 'Validity of estimate of measure of effectiveness' therefore apply.
Validity of estimate of costs
All the categories of cost relevant to the perspective adopted (i.e. MCO) were included in the analysis. All the costs related to the set up and running of the Right Start programme were appropriately reported by category of cost. However, the authors did not report the costs included when estimating the costs of low birth weight infants and normal weight infants during their first year of life. It is therefore not possible to say if any major costs in this category were omitted from the analysis. The costs and the quantities were not reported separately, which will limit the generalisability of the authors' results. The costs were derived from the authors' settings. No sensitivity or statistical analyses of the costs were performed to test for uncertainty, or to examine if the costs were significantly different between the two groups. Discounting was unnecessary, as all the costs were incurred during one year, and was not performed. The price year was reported, which will aid any future inflation exercises.
Other issues
In terms of comparisons with other studies, the authors reported that preliminary work had suggested that education and nursing interventions targeting prenatal enrollees decreased the incidence of low birth weight infants and improved birth outcomes. The issue of generalisability to other settings was not addressed. The authors do not appear to have presented their results selectively and their conclusions reflected the scope of the analysis. The authors reported the main limitation of their study was that, without the 'gold' standard of randomised double-blind trials, it was difficult to prove if the Right Start programme alone was successful.
